Neurol India Home 
 

CORRESPONDENCE
Year : 2016  |  Volume : 64  |  Issue : 5  |  Page : 1101--1102

Author's reply: Cell therapy for neurological disorders: The elusive goal

Prakash N Tandon 
 Department of Neurosurgery, National Brain Research Institute, Manesar, Haryana, India

Correspondence Address:
Prakash N Tandon
Department of Neurosurgery, National Brain Research Institute, Manesar, Haryana
India




How to cite this article:
Tandon PN. Author's reply: Cell therapy for neurological disorders: The elusive goal.Neurol India 2016;64:1101-1102


How to cite this URL:
Tandon PN. Author's reply: Cell therapy for neurological disorders: The elusive goal. Neurol India [serial online] 2016 [cited 2020 Aug 8 ];64:1101-1102
Available from: http://www.neurologyindia.com/text.asp?2016/64/5/1101/190296


Full Text



Sir,

Thanks for sending me the comments of Dr. Sunil Pandya on our review “Cell Therapy for Neurological Disorders; the elusive goal. Neurology India 2016;64:612-623.”[1] I totally agree with every statement made by him. Yes, we had consciously avoided reference to the several malpractices prevalent in the country. The only justification for this, not simply an excuse, was that though fully aware of these malpractices, we did not wish to mention anything which was not based on objectively verified and published facts. I am afraid I was not aware of Dr. Pandya's paper of 2008. With regards to an “agency in India that can monitor such practices,” Dr. Pandya is factually correct. However, for the readers of Neurology India, let me say that Indian Council for Medical Research (ICMR) along with Directorate of Biotechnology (DBT) have published “Guidelines for Stem Cell Therapy” and a registry has been established at ICMR which mandates that everyone pursuing or practicing stem cell therapy should register with ICMR. Unfortunately those guidelines have not been legislated so a monitoring mechanism does not exist, nor is there any law to penalize the defaulter. I fully agree with Dr. Pandya that the Neurological Society of India, as also Neurology India, should take up this cause. One of the purposes of our review was to update the neuroscience community in the country with the available scientific evidence so as to prevent unscientific use of cell therapy and deter the un-informed hype.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest

References

1Tandon PN, Pankaj S. Cell therapy for neurological disorders: The elusive goal. Neurology India 2016;64:612-23.